SAPHYR Trial: Sarilumab Wins in Relapsing Polymyalgia Rheumatica NEJM reported today that #PMR patients who fail to re

Social Author Image
https://pbs.twimg.com/profile_images/1215290012490702848/mq73skc3_normal.jpg
Tweet Author
RheumNow
Social Author Name
Dr. John Cush
Tweet Content
SAPHYR Trial: Sarilumab Wins in Relapsing Polymyalgia Rheumatica NEJM reported today that #PMR patients who fail to respond to standard doses of prednisone therapy, were significantly better when given the IL-6 inhibitor sarilumab (than placebo). https://t.co/k5SAshxdsg https://t.co/tMtRHn2C6j
Links
SAPHYR Trial: Sarilumab Wins in Relapsing Polymyalgia Rheumatica | RheumNow https://bit.ly/3M0MZ7o
Show on Archive Page
On
Display in Search Results
On
PDQ
Off

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright {{ 'now'|date('Y') }} All Rights Reserved.